Patents by Inventor Ralph Niven

Ralph Niven has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20240130966
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: February 15, 2022
    Publication date: April 25, 2024
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20240108622
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: October 6, 2023
    Publication date: April 4, 2024
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20240041879
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: October 11, 2023
    Publication date: February 8, 2024
    Inventors: Ben Dake, Ralph Niven
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11813263
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: November 14, 2023
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11806349
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: January 24, 2022
    Date of Patent: November 7, 2023
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20230086230
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: August 15, 2022
    Publication date: March 23, 2023
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20230056721
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: October 11, 2022
    Publication date: February 23, 2023
    Inventors: Ben Dake, Ralph Niven
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11464776
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: October 11, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11413289
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: August 16, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20220218706
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: January 24, 2022
    Publication date: July 14, 2022
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11298355
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: April 12, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11229650
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: January 25, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20200375895
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: December 3, 2020
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB METABOLITE FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20200360276
    Abstract: The invention relates to inhalable imatinib metabolite formulations, manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE FORMULATIONS OF IMATINIB, IMATINIB METABOLITES, IMATINIB SALTS, THEIR MANUFACTURE, AND USES THEREOF
    Publication number: 20200360277
    Abstract: The invention generally relates to inhalable formulations of imatinib, imatinib metabolites, imatinib salts, their manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20200360275
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20200360377
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Ben Dake, Ralph Niven
  • INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
    Publication number: 20200360376
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • NASAL IRRIGATION SYSTEMS
    Publication number: 20130012869
    Abstract: Nasal irrigation systems for irrigating and/or rinsing a subject's nasal cavity are disclosed herein. Irrigation fluid may be drawn through the nasal cavity while utilizing a staged treatment procedure which allows for an initial infusion or flushing of irrigation fluid, circulation of the fluid, and subsequent flushing of the effluent from the nasal cavity. The system allows for reversible flow of the fluid during irrigation as well as use of vibration to disrupt debris within the nasal cavity to facilitate the mixing and removal of the debris. Additionally, peristaltic flow of the irrigation fluid may be used to facilitate contact between the fluid and debris during fluid circulation. Moreover, the irrigation fluid may also incorporate air or a gas into the fluid flow to create discrete volumes or boluses of pressured fluid to further facilitate thorough irrigation of the nasal cavity.
    Type: Application
    Filed: July 10, 2012
    Publication date: January 10, 2013
    Inventors: Albert CHA, John SPIRIDIGLIOZZI, Ralph NIVEN
  • Pulmonary surfactant formulations
    Patent number: 8337815
    Abstract: Synthetic pulmonary surfactant compositions comprising dipalmitoyl phosphatidylcholine, phosphatidylglycerol, and essentially neutral lipid, and having essentially no 1-palmitoyl 2-oleoyl phosphatidylglycerol and essentially no palmitic acid are provided. Methods for treating respiratory disease are also provided comprising administering a therapeutically effective amount of a synthetic pulmonary surfactant comprising dipalmitoyl phosphatidylcholine, phosphatidylglycerol, and essentially neutral lipid, and having essentially no 1-palmitoyl 2-oleoyl phosphatidylglycerol and essentially no palmitic acid.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: December 25, 2012
    Assignee: Discovery Laboratories, Inc.
    Inventors: Maithili Rairkar, Rom E Eliaz, Ralph Niven, Mark E. Johnson